Baseline characteristics
| Study | Mean age (years) | Male (%) | HT (%) | CAD (%) | DMII (%) | Smoking (%) | Alcohol (%) | Dyslipidemia (%) | Hyper- cholesterolemia (%) | Antiplatelets (%) | Anticoagulants (%) | AF (%) | Prior stroke (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Singer et al22 | 71* | 65 | 72 | – | 21 | 17 | – | – | 24 | 30 | 12 | 34 | – |
| Gory et al13 | 60* | 64 | – | – | – | – | – | – | – | – | – | – | – |
| Son et al23 | 67.4 | 68 | 48 | – | 39 | 32 | 48 | 61 | – | – | – | 45 | 58 |
| Mourand et al18 | 61±17 | 48 | – | – | – | – | – | – | – | – | – | – | – |
| Mohlenbruch et al16 | – | – | – | 21 | – | – | – | – | – | 42 | 4 | – | – |
| Lefevre et al14 | – | – | – | – | – | – | – | – | – | – | – | v | – |
| Fesl et al12 | 81.7 | 64 | – | – | – | – | – | – | – | 14 | 15 | – | – |
| Baek et al1 | 68 | 56 | 60 | 8 | 32 | 24 | – | 24 | – | – | 4 | 36 | 27 |
| Raoult et al21 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Park et al20 | 68±11 | 75 | 75 | – | 44 | – | – | – | – | – | – | 19 | 25 |
| Nagel et al19 | 33 | 63 | 22 | 27 | 17 | – | – | 24 | 52 | – | 27 | 27 | |
| Mordasini et al17 | 64.5* | 57 | 57 | 21 | 14 | 36 | – | – | 57 | – | 50 | 21 | 21 |
| Espinosa et al4 | 67.5 | 39 | 78 | 7 | 33 | – | – | – | – | 33 | 11 | 28 | – |
| Andersson et al11 | – | 71 | – | – | – | – | – | – | – | – | – | – | – |
| Dorn et al3 | – | 57 | – | – | – | – | – | – | – | – | – | – | – |
| Miteff et al15 | 59±15 | 50 | – | – | – | – | – | – | – | – | 10 | – | – |
| Costalat et al2 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Minimum | 59 | 33 | 48 | 7 | 14 | 17 | 48 | 24 | 24 | 14 | 4 | 19 | 21 |
| Maximum | 82 | 75 | 78 | 22 | 44 | 36 | 48 | 61 | 57 | 52 | 50 | 45 | 58 |
| Weighted Average | 67 | 59 | 67 | 16 | 26 | 21 | 48 | 44 | 26 | 34 | 13 | 33 | 34 |
*Median.
AF, atrial fibrillation; CAD, coronary atherosclerotic disease; DMII, diabetes mellitus type II; HT, hypertension.